• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Brisbane Strain

Commonground

Senior Moderator
A timeline of excerpts from articles I found very interesting regarding the Brisbane Strain.

07 February 2008

Profile: Vaccine trailblazer
Hepeng Jia/Beijing, China
When Yin Weidong, general manager of the vaccine developer Sinovac Biotech, established his company to develop a hepatitis A vaccine in 1992, he hadn't even heard the term 'biotech'.

Now, 15 years on, Yin is one of the leading lights of China's fast growing biotech industry and Sinovac the first Chinese biotech firm listed on the US stock exchange.
With no sign of another epidemic, the company has recently decided to suspend its SARS vaccine programme despite successful results from its phase I trial. The phase III trial of its H5N1 vaccine is also on hold.
http://www.rsc.org/chemistryworld/News/2008/February/08020802.asp



15 February 2008

WHO names three new strains for 2008 flu vaccine
Replacing all three strains in the flu shot is rare and could complicate the process of making next winter's vaccine, experts agree.
"The manufacturers will have a challenge ahead of them. We all will," said Dr. Nancy Cox,...
Cox said changing all three strains is "not unprecedented" but doesn't happen often.

"This year our data were just very consistent in pointing to the need to update H1, H3 and B," she said, referring to the three components in the vaccine.
"We're looking for new variants, the spread of those variants...
The recommended strains for next winter's vaccine are named A/Brisbane/59/2007, which is the H1N1 virus; A/Brisbane/10/2007, which is the H3N2 virus; and B/Florida/4/2006.

The last two are in the vaccine which is being prepared now for the southern hemisphere's upcoming flu season, so the vaccine manufacturers have some experience working with two of the three. But one of those two - the H3N2 virus - grew poorly and produced a low yield.
http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/20080215/flu_vaccine_080215/20080215?hub=Health



21 February 2008

Officials hope 2009 flu vaccine protects better
"It's going to be a really busy spring and summer, and of course we're always looking for fallback positions just in case things don't work out well," said Dr. Nancy Cox,....
One concern: A strain called Brisbane/10 that's responsible for much of this winter's misery doesn't grow very quickly in the laboratory, potentially complicating already laborious vaccine production

CDC and international authorities expect Brisbane/10, a version of the H3N2 flu, to still be around next year. They predict a second new Type A strain, known as H1N1/Brisbane/59, also will hit, along with a newer Type B/Florida strain, prompting Thursday's decision to put all three in next year's vaccine.
The recipe must be set about eight months before manufacturers start shipping doses because flu vaccine production is so complex. Health authorities come up with seed stocks of the virus strains that manufacturers then must grow in chicken eggs.
Makers of vaccine for the Southern Hemisphere already have added the troublesome Brisbane/10 strain to their own shots, and found it doesn't grow easily. Scientists now are working on a solution to that technical problem, such as using a very similar virus -- it's even called "Brisbane/10-like" -- found in Uruguay that would provide the same protection, Cox said.
"We're working with three new strains. ... There's some unknowns related to those and how they're going to grow."
http://www.cnn.com/2008/HEALTH/02/21/next.flu.vaccine.ap/index.html

06 March 2008

Hong Kong
Vigilance against seasonal influenza urged
Speaking at a media briefing today (March 6), the Controller of CHP, Dr Thomas Tsang, said that CHP's surveillance systems indicated an increased influenza activity in recent weeks indicating Hong Kong was now in the traditional winter influenza season.
This year, circulating influenza viruses showed a mixed composition, with A/H3N2/Brisbane, A/H1N1/Solomon Islands, A/H1N1/Brisbane and B/Yamagata and B/Malaysia.
http://www.info.gov.hk/gia/general/200803/06/P200803060180.htm


17 March 2008

Flu jabs planned for Hong Kong kids
GUANGZHOU - Hong Kong is planning free flu vaccinations for 1 million children aged 12 and under to prevent further spread of the epidemic.
http://www.chinadaily.com.cn/china/2008-03/17/content_6540372.htm


18 March 2008

Scott McPherson’s Blog
Facts are stubborn things.
And timelines here are important. First, Teenage girl develops coinfection with H5N1 and H3N2 in April, 2007. Next, Aussies travel to Bali in droves, as Bali is to Australians what Disney World is to people from Illinois. Next, Australia types a new and more virulent substrain of H3N2, called Brisbane, in Summer, 2007. Then, that same substrain moves to North America and Europe in 2007 and 2008.

Look at the quote from Emmy's article:
A virologist and microbiologist at Udayana University in Denpasar (Bali), I Gusti Ngurah Mahardhika, said the co-infection involving the girl most likely was not the first such case in Indonesia because researchers used to focus only on H5N1 and did not check for the presence of other H viruses. (bold mine)
"Global fear of a new virus from such a co-infection is well grounded, I think. The product of a reassortment between H5N1 and H3N2 can be still in the form of H5N1 but with traits of H3N2. The new H5N1 is virulent and has the capacity to transmit from human to human like H3N2, our seasonal flu virus," he said.


Only after looking at the genetic makeup of A/H3N2 Brisbane will we know if it acquired any Indonesian H5N1 human polymorphisms. But in light of this latest peer-reviewed, scientific paper, and considering where and when H3N2 Brisbane came from -- I think it is worth a serious look. Don't you?
Because facts are stubborn things, indeed.
http://www.scottmcpherson.net/display/ShowJournal?moduleId=1366394&categoryId=116462&currentPage=4

22 March 2008

Australia
Deadly flu warning
PARENTS should vaccinate their children against influenza to prepare for a potentially deadly flu season this year, the World Health Organisation has warned. [snip]

In 2007, Queensland had the highest rate of laboratory-confirmed influenza in the country with 4268 cases, followed by New South Wales with 1640 cases, and Victoria with 1497. There were only 1213 cases recorded for the entire country in 2006.

It is understood another antiviral medication, Relenza, made by GlaxoSmithKline, may still work against the H1 mutated strain.
http://www.news.com.au/couriermail/story/0,23739,23416091-953,00.html[/quote]


07 April 2008

Australia
Free flu jabs for all toddlers [not a typo, see March 17th above]
“Influenza strains are becoming stronger and more unpredictable and the very young, the elderly and those with chronic disease are all vulnerable to severe illness from the virus,”...
In 2007 there were four times the number of confirmed cases as were reported the previous year.
A $700,000 Department of Health advertising campaign to warn people of the dangers and advise them on how to avoid getting and transmitting the virus will begin tomorrow.
http://www.news.com.au/perthnow/story/0,21598,23497278-948,00.html



10 April 2008

Australia
Flu jab patients turned away due to shortage
The WA Health Department blamed the temporary shortage of the vaccine on changes to the influenza virus which had made the manufacture of this year’s vaccine more time-consuming.
“Because of changes to the influenza virus circulating in Australia last winter and in the northern winter, the influenza vaccine this year has three totally new vaccine components,”
http://www.thewest.com.au/default.aspx?MenuId=77&ContentID=67327
 
Last edited:
Re: Brisbane Strain

http://www.cnn.com/2008/HEALTH/02/21/next.flu.vaccine.ap/index.html

07 April 2008

Australia
Free flu jabs for all toddlers [not a typo, see March 17th above]
?Influenza strains are becoming stronger and more unpredictable and the very young, the elderly and those with chronic disease are all vulnerable to severe illness from the virus,?...
In 2007 there were four times the number of confirmed cases as were reported the previous year.
A $700,000 Department of Health advertising campaign to warn people of the dangers and advise them on how to avoid getting and transmitting the virus will begin tomorrow.
http://www.news.com.au/perthnow/story/0,21598,23497278-948,00.html
http://www.thewest.com.au/default.aspx?MenuId=77&ContentID=67327
More from above article

?Two drug companies, Sanofi and CSL, have offered $800,000 worth of free flu vaccines for Perth children. This will form the basis of an Australian-first study to explore whether the vaccine should be made available for free to all children across the country....

..Perth was selected for the study because it was judged as having the best influenza surveillance program in Australia. About 350,000 free flu vaccines, worth more $3.25million will be available for children and eligible adults over the coming months.
 
Re: Brisbane Strain

The following from A review of production technologies for influenza virus vaccines, and their suitability for deployment in developing countries for influenza pandemic preparedness
http://www.who.int/vaccine_research/diseases/influenza/Flu_vacc_manuf_tech_report.pdf


Influenza vaccines: background
3.1 Seasonal influenza vaccine
3.1.1 Annual cycle of influenza vaccine production
Surveillance
Surveillance is undertaken year-round to monitor influenza strains in the population, and at the start of the influenza season WHO announces which dominant circulating strains should be included in the vaccine (Gerdil, 2003).
Seed strains
WHO Collaborating Centres generate and analyse the seed strains for vaccine production. Since the 1970s, this has been done by genetic re-assortment. Embryonated eggs are co-infected with the field strain selected for the vaccine and an A/PR8/34 (or similar) master strain that is known to give good yields on eggs. High-growth progeny virus is analysed to confirm the presence of surface glycoproteins from the field strain. (Gerdil, 2003).
Vaccine seed strains are distributed to the vaccine producers in order to evaluate their suitability for vaccine production. Factors such as yield when grown in eggs, antigenic stability, inactivation and purification process are evaluated. The results from all the producers are evaluated in meetings with the EMEA and FDA, typically held one month after the initial WHO decision on formulation (Gerdil, 2003).

..

Yield in eggs. Many years of experience producing reassortant viruses as vaccine strains have made this technology robust and reproducible. However, individual virus isolates may exhibit different growth characteristics in eggs, thereby affecting the yield of the manufacturing process. This might particularly be the case with an avian-derived pandemic strain. Experience to date with H5N1 viruses generated by reverse genetics has shown that these reassortant viruses produce only 30-40% of the yield of HA of seasonal vaccine strains, despite growing to normal titres in eggs.

http://www.who.int/vaccine_research/diseases/influenza/Flu_vacc_manuf_tech_report.pdf
 
Re: Brisbane Strain

More from the 15 February article:


"The manufacturers will have a challenge ahead of them. We all will," said Dr. Nancy Cox, head of the U.S. Centers for Disease Control's influenza division and one of the international experts who gathered at the WHO in Geneva this week for the vaccine strain selection meeting.

Because it takes months for vaccine manufacturers to grow the viruses in eggs and then process the yield into vaccine, experts involved in strain selection meet long in advance of flu season to determine what the vaccine should target.

At the gathering in Switzerland, they studied data about which viruses have been circulating where and which seem to be causing the most disease, using it to predict what viruses would be expected to launch the biggest assaults on human immune systems in the northern hemisphere in the winter of 2008-09.

A similar meeting is held each September for selection of the strains for the vaccine for the southern hemisphere's winter.
http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/20080215/flu_vaccine_080215/20080215?hub=Health

So the decision was made the week of February 15th 2008. 7 days earlier, Sinovac Biotech decides to put Phase III on "hold".
They met in September of 07 to decide on the southern hemisphere's selection.
Just trying to fit the puzzle pieces in. Thinking out loud.
 
Back
Top